Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchial thermoplasty for asthma.

Gerard Cox1, John D Miller, Annette McWilliams

  • 1M.B., Firestone Institute for Respiratory Health-T2123, St. Joseph's Healthcare, 50 Charlton Avenue, East Hamilton, ON L8N 4A6, Canada. coxp@mcmaster.ca

American Journal of Respiratory and Critical Care Medicine
|February 4, 2006
PubMed
Summary

Bronchial thermoplasty (BT) is safe and well-tolerated for asthma patients, significantly reducing airway hyperresponsiveness for at least two years. This treatment improves asthma symptoms and lung function over time.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia.

The Medical journal of Australia·2026
Same author

Prevalence, detection, and trajectory of combined pulmonary fibrosis and emphysema.

Chest·2026
Same author

'The evidence is out there…': perspectives of healthcare providers on improving asthma and COPD prevention and care within a major health authority region of British Columbia, Canada.

BMJ open quality·2026
Same author

Clinical and Radiologic Characteristics of Familial Pulmonary Fibrosis.

Annals of the American Thoracic Society·2026
Same author

Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease.

Respiratory medicine·2026
Same author

Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types.

PLoS computational biology·2026

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology

Background:

  • Bronchial thermoplasty (BT) targets smooth muscle-mediated bronchoconstriction by reducing airway smooth muscle mass.
  • Asthma management often involves addressing airway hyperresponsiveness.

Purpose of the Study:

  • To evaluate the safety of bronchial thermoplasty (BT) in patients with mild to moderate asthma.
  • To assess the long-term impact of BT on lung function and airway responsiveness over a two-year period.

Main Methods:

  • A safety study involving 16 asthma subjects.
  • Measurements included spirometry, methacholine challenge, and daily symptom/peak flow diaries.
  • Follow-up evaluations were conducted at 12 weeks, 1 year, and 2 years post-treatment.

Main Results:

Related Experiment Videos

  • BT was well-tolerated with transient side effects similar to bronchoscopy.
  • Significant improvements in airway responsiveness (PC20) were observed at all follow-up points (12 weeks, 1 year, 2 years).
  • Daily diary data showed improvements in symptom-free days and peak flow measurements; spirometry remained stable.

Conclusions:

  • Bronchial thermoplasty (BT) demonstrates good tolerability in asthma patients.
  • BT leads to a sustained reduction in airway hyperresponsiveness for at least two years.
  • The procedure offers a promising therapeutic option for managing asthma symptoms and airway reactivity.